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1. Introduction
Psychogenic non-epileptic seizures (PNES) are paroxysmal involuntary changes in behaviour,
sensation, motor activity, cognitive processing or autonomic function that resemble epileptic
seizures (ES). However, they have no electrophysiological correlate but instead possess a
psychological origin [1, 2].
Historically known as hysteria seizures by Hippocrates and Aristotle, the French neurologist
Jean-Martin Charcot recognised hysteria as a neurologically diagnosable condition. Many
years after this recognition, Sigmund Freud reclassified hysteria as a psychiatric disorder.
Previously, PNES has been given various names, such as pseudoseizures, non-epileptic spells
or psychogenic seizures. In general, this terminology involving the prefix ‘pseudo-’ has become
out-dated as it implies that the seizures are not real and may suggest ‘malingering’.
PNES have been commonly classified as dissociative or conversion disorders. However, PNES
have also been considered to be very similar to other functional somatic symptoms and
syndromes [3]. In the current and recently published DSM-V, PNES are classified as a “func‐
tional neurological symptom disorder”. It appears that PNES are not a single entity and that
a variety of clinical manifestations can occur. Furthermore, comorbid psychiatric disorders are
common; thus, it is not surprising that a PNES diagnosis is difficult to achieve. PNES exist at
the interface of neurology and psychiatry and as discussed below, constitute an important
challenge in the practice of both medical specialties, because of their inherent diagnostic and
therapeutic difficulties.
© 2014 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Misdiagnosis leads to iatrogenic effects of antiepileptic medication and aggressive or invasive
procedures, such as intubations during emergency department visits [4]. After initial symptom
onset, the average time to a formal PNES diagnosis is 7 to 9 years [2, 4, 5].
Video-electroencephalography (vEEG) monitoring is an indispensable tool for diagnosing
PNES because it allows the simultaneous analysis of both clinical and ictal EEG findings. In
some cases, provocative techniques aid in diagnosing PNES, and these are performed only
when necessary and in approximately 30-50% of patients diagnosed with PNES [6]. These
techniques are very useful in detecting the presence of suggestibility, which strongly supports
a psychogenic mechanism.
Approximately 25-30% of epilepsy patients referred to tertiary epilepsy centres or specialised
hospitals have PNES [7]. The incidence of PNES is approximately 4% of the total epilepsy
incidence [8], and in fact, most patients misdiagnosed with epilepsy at epilepsy centres have
PNES [9]. These patients are heavy users of emergency and nonemergency health care [10],
and approximately three fourths receive inappropriate AED treatment before their diagnosis
[11], which can produce adverse side effects, high costs to health care facilities, high medical
utilisation rates and high personal and societal costs.
At present, PNES are considered symptoms of an underlying psychological or psychiatric
disorder and are associated with impaired social function [12] and high disability [13, 14] that
affect patient quality of life [15, 16]. Disability and quality of life may even be poorer than in
epilepsy patients [12, 14, 17]. Additionally, PNES patients have been reported to be twice as
likely to be unemployed as patients with epilepsy [12].
PNES seem to occur more frequently in women [18] but also may be more difficult to recognise
in men [19]. Gender differences in clinical presentation have been reported, and males have
shown higher seizure frequencies, more antiepileptic drug use, and a longer interval before
PNES diagnosis [12]. Most patients experienced PNES onset at a young age, and approximately
10% of patients experienced PNES onset after the age of 60 [20].
Furthermore, patients from lower sociocultural classes are more likely to experience PNES [4].
A small number of clinical studies have observed differences in the cognitive profiles of
patients with PNES versus patients with epilepsy [21].
A PNES diagnosis is a very common and important diagnosis in epilepsy units and is described
as a common condition associated with epilepsy (PNES+ E). In this study, we attempted to
depict and describe the characteristics of PNES patients and the difficulty of diagnosis in a
national referral centre for epilepsy surgery. In light of the current literature, the physiopa‐
thological hypothesis, treatment and prognosis should be revised.
2. Methods
2.1. Patients
We retrospectively reviewed all patients with an intractable epilepsy diagnosis admitted to
the National Referral Centre for Epilepsy Surgery at the Hospital Universitario de la Princesa
Epilepsy Topics194
between July 2001 and July 2013. All patients underwent prolonged video-electroencephalog‐
raphy (vEEG) monitoring as part of the evaluation for surgical treatment [22, 23]. The evalu‐
ation also included psychiatric, psychological and clinical evaluations, scalp EEG, 1.5T
magnetic resonance imaging (MRI) and interictal single photon emission-computed tomog‐
raphy (SPECT) with 99mTc-HmPAO. vEEG monitoring was conducted using 19 collodion-fixed
scalp electrodes, according to the international 10-20 system. During vEEG recordings,
antiepileptic drugs were progressively removed from the second to the fourth day of record‐
ings at a rate of approximately one-third of the dose per day. The digital EEGs (NeuroWorks,
XLTEK®, Oakville, Canada) were sampled at 512 Hz and filtered at 0.5-70 Hz with a notch
filter of 50 Hz. Accessory electrodes were used to monitor electromyography (EMG) at
different muscles in combination with an electrocardiogram (EKG).
The following criteria were used to diagnose PNES: (1) at least one single typical clinical event
captured on vEEG, (2) the EEG recording did not detect any concomitant ictal activity or
postictal slowing, and (3) no evidence of any alternative neurological diagnosis (e.g., move‐
ment disorders) [3]. An epilepsy diagnosis was assigned according to the International League
Against Epilepsy (ILAE) classification system [24]. The provocative protocol technique with
placebo was utilised in cases where discordance was observed between the clinical and
electrical findings.
2.2. Induction techniques
We used induction techniques to support the diagnosis of PNES when considered useful [25].
The systematic steps in the provocative induction technique with placebo utilised in our
epilepsy unit were [26]:
All patients received verbal information and signed an inform consent document stating the
need for a test with a drug that could induce their seizures. The informed consent was accepted
by the Hospital’s ethical committee.
Two neurophysiologists were present and monitored the entire study.
Bioelectrical brain function and behaviour was simultaneously monitored by vEEG.
The following cardiorespiratory parameters were monitored: EKG, respiratory rate, capillary
saturation oxygen (SaO2) and blood pressure.
Two millilitres of a saline solution were intravenously injected. When a typical seizure
appeared, a second 2-ml bolus of saline was administered to terminate the event.
Psychiatric assessment
Diagnoses were determined according to the DSM-IV-TR criteria (Diagnostic and Statistical
Manual of Mental Disorders, fourth edition, text revision, Axis I Disorders).
All patients were evaluated with a non-structured clinical assessment interview according to
the Protocol of Psychiatric Assessment for our Epilepsy Surgery Unit (Table 1).
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The psychiatric assessment of all patients included the following:
Mental health exploration to identify current psychiatric disorders.
History of psychiatric disorders.
Personality traits.
History of drug abuse and previous and current psychopharmacologic treatments, including benzodiazepines,
antidepressants and antipsychotic drugs.
Previous abuse or childhood trauma.
A neuropsychological assessment including IQ, verbal and manipulative IQ, total, verbal and visual memory and
executive function tests.
Table 1. Patient psychiatric assessment
2.3. Statistical analysis
Statistical comparisons between groups were performed using Student’s t-test (two groups)
or analysis of variance (more than two groups) for parametric samples. For non-parametric
samples, the Mann-Whitney test (two groups) and the Kruskal-Wallis test (more than two
groups) were used. The sample fit to a Gaussian distribution was assessed by the chi-square
or Kolmogorov-Smirnov tests.
The SigmaStat 3.5 software (SigmaStat, Point Richmond, CA, USA) was used for the statistical
analysis. The significance level was set at p < 0.05. The results are presented as the mean ± SEM,
except where otherwise indicated.
For patients in whom differential diagnosis was especially difficult, a numerical analysis of
EEG recordings was performed to differentiate between epilepsy and PNES by developing a
custom program with Matlab R2008 software (MathWorks, Natic, USA).
Recordings of bioelectrical activity occurring prior to the seizure and during the epileptic event
were exported as ASCII files for analysis. For every channel, a Butterworth digital filter from
0,5 to 70 Hz (notch filter, 48-52 Hz) was applied. Artefact free periods of 5 to 10 s were divided
in N non-overlapping windows of 1024 points each, and no software was used to remove
electrooculogram signals. We calculated the fast Fourier transform (FFT) for every channel
(Xi; i=1, 2,...19). The power spectrum (Si; i=1, 2,...19) was divided into the EEG frequency bands
delta (0.5-4 Hz), theta (4-8 Hz), alpha (8-13 Hz) and beta (13-30 Hz), and the total area under
the curve was computed. (Si,k; i=1, 2,...19; k=1, 2,...N). Cross-spectra between channels i and j
(Sij) were also calculated for all channel pairs. Coherence [27] for the frequency, f, and for every
channel pair, i and j, is defined according to the following expression:
C( f )= | Sij( f ) N |
2
Sii( f ) N S jj( f ) N (1)
Local coherence (c) was obtained from neighbouring channels according to the following
expression [28]:
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c( f )= 1p ∑i=1
p Ci (2)
Where p is the number of electrodes that were computed.
Statistical comparisons between each channel before and during seizures were performed.
3. Results
3.1. Patient classifications
A total of 630 patients were included in this study. We classified the patients into 4 diagnostic
groups according to the following criteria (Table 2) [26]:
• Epilepsy: clinical and bioelectrical evidence of epileptic seizures were confirmed. We did
not distinguish between partial and generalised epilepsy because that classification was
outside the scope of this work.
• No evidence of seizures: in these cases, the data suggested epilepsy (abnormal epileptiform
activity in the vEEG), but no seizures occurred after a sufficient period of time without
medication (usually more than 2 weeks).
• No evidence of epilepsy: no epileptiform activity or any clinical event was observed during
vEEG recordings that supported a PNES or epilepsy diagnosis.
• PNES: at least one typical clinical event was captured on vEEG but without concomitant
epileptiform bioelectric characteristics or other justifiable organic causes.
n %
Epilepsy 554 87,9
No evidence of seizures 23 3,7
No evidence of epilepsy 23 3,7
PNES 30 4,7
Table 2. Diagnostic classifications of patients.
We analysed the clinical features of PNES and epilepsy patients. The mean age of the PNES
patients was 33,9 ± 1,7 years old, and the mean age of epileptic patients was 34,3 ± 0,5 years
old (p < 0,05, Student's t test). The average age of seizure onset was 15,6 ± 2,0 years old for
PNES patients and 11,9 ± 0,4 years old for epilepsy patients (n.s., Student's t test).
The mean seizure frequency for epileptic and PNES patients is shown in Figure 1.
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Figure 1. Mean seizure frequency for PNES (filled bars) and epileptic patients (empty bars).
Females represented a greater percentage of PNES patients (20/30). In addition, 70% of PNES
patients presented with comorbid epilepsy (PNES+E, 12/21) or epileptiform activity (PNES
+EA, 9/21), which were verified by EEG recordings (Table 3). Nine of the 30 patients were
diagnosed with PNES alone.
Patient
Number
Age
(years)
Age of
Onset
(years)
SPECT MRI vEEG Engel'sscale
Placebo/
Response
Psychiatric
Disorder(s)
1 18 18 Normal Normal _ PTSD
2 31 7 Normal Normal _ DS
3 30 2 Bi-T Tuberose Sclerosis L-T AE _ Yes/Yes DS
4 29 Bi-T Normal Petit malEpilepsy _ Anxiety
5 19 1 Bi-T Bi-TMS L-T AE _ Yes/No No
6 19 16 Bi-T Multiplecavernomas L-TLME _ Dysthymia
is
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Patient
Number
Age
(years)
Age of
Onset
(years)
SPECT MRI vEEG Engel'sscale
Placebo/
Response
Psychiatric
Disorder(s)
7 47 9 Bi-T SubcorticalHyperintensities R-T AE _ No
8 37 8 L-T Normal GE _ Yes/Yes No
9 19 16 Normal Normal _ Yes/No DS
10 55 3 R-MT Normal Bi-T EA _ Yes/Yes No
11 37 31 Normal Normal L-TLE II Anxiety
12 33 3 Bi-T Surgical changes Bi-T EA _ Yes/Yes No
13 32 3 Irregularperfusion
R-F
Encephalomalacia R-FLE Yes/Yes No
14 49 26 R-MT R-MTS R-MTLE I Yes/Yes No
15 28 15 Normal Normal _ DS
16 35 30 L-T L-T anterior hornincrease _ No
17 49 35 R-MT R-T anterior hornincrease R-T EA _ Depression
18 41 28 L-T L-MTS L-T EA _ Depression
19 37 14 Bi-FT Bi-FP ischemicalterations _ No
20 40 1 L-TM Normal G- EA _ No
21 16 13 L-MT L-MTS _ Yes/Yes No
22 33 14 R-MT Normal _ No
23 41 27 L-FP Normal _ No
24 40 23 Irregularperfusion
L Hippocampal
dysplasia L-T EA _ Anxiety
25 32 8 L-FT R-MTS L-FLE I Depression
26 38 29 R-MT Normal L-MTLE _ No
27 35 2 L-MT L-MTS L-MTLE I Anxiety
28 48 23 R-MT Normal L-MTLE I Anxiety
29 27 1 R-MT R-MTS R-MTLE _ No
30 33 20 Bi-F R-F Hyper-intensitiesWM L-MTLE _ Depression
Table 3. Characteristics of PNES patients.
Bi, bilateral; DS, dissociative disorders; EA, epileptiform activity; F, frontal; FLE, frontal lobe
epilepsy; FP, fronto-parietal; FT, fronto-temporal; GE, generalised epilepsy; L, left; MT, mesial
temporal; MTLE, mesial temporal lobe epilepsy; MTS, mesial temporal sclerosis; PTSD, post-
traumatic stress disorder; R, right; T, temporal; TLE, temporal lobe epilepsy; WM, white
matter.
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The semiology of PNES was highly stereotyped in each patient and mainly consisted of
convulsive components or bizarre bilateral motor manifestations involving the upper or lower
limbs. Other manifestations lacked motor events but involved sensory feelings or unrespon‐
siveness, although these stereotypies were less frequent.
Importantly, in the PNES+E group, structural abnormalities were evident in 11/12 neuroimag‐
ing studies. We also found that in patients diagnosed as PNES+EA, structural abnormalities
associated with temporal lobe epilepsy were observed in 9 patients. Moreover, 3 patients
presented with mesial temporal sclerosis in MRI studies.
When we assessed the PNES group with the same tests, we found that there were cerebral
perfusion abnormalities on SPECT in 6/9 patients and that in 3/9 patients, MRI showed lesions
sometimes associated with temporal lobe epilepsy (TLE).
In PNES+E patients, there were 8 cases of temporal lobe epilepsy, 2 cases of frontal lobe
epilepsy, and 2 cases of generalised epilepsy. Also in this group, the following surgical
interventions were utilised: temporal lobectomy (4 patients), and frontal lobectomy (1 patient)
with an Engel’s scale outcome of I in 4 and II in 1.
3.2. Provocative techniques
A provocative placebo technique was used to confirm a PNES diagnosis in 9 patients with an
inconclusive diagnosis from vEEG monitoring. In 7 patients, the provocative test was positive
for PNES, and in those cases, the patients experienced similar episodes to the previously
recorded spontaneous episodes. However, a variable delay (of less than a minute) between
saline administration and symptom onset was observed. The recorded bioelectric activity
during the induced, as well as during spontaneous episodes, was completely normal, with
visible muscle and movement artefacts. After a varying 30- to 60-second period after the
episode started, we administered a second dose of saline after warning the patient that this
drug would abort the crisis, which indeed occurred with a latency between 15 and 45 s. One
example of this technique is shown in Figure 2.
Provocative induction was positive for PNES in 7 patients. However in the other two patients
we did not obtain any response.
3.3. Diagnostic challenges
Prolonged vEEG monitoring provides a definitive PNES diagnosis in nearly all cases. How‐
ever, in some situations, a definitive PNES or epilepsy diagnosis can be difficult to obtain.
Here, we describe a case in which the semiology and vEEG did not confirm that the episode
was psychogenic in origin. Quantitative EEG (qEEG) had been used to assess the patient by
both spectral and coherence methods while recording EEGs during basal conditions and
episodes.
This patient, a 29 year old female, experienced seizure onset at 9 years old. The clinical
symptomatology was described as an inability to emit and understand language, with feelings
of sadness and fear. Moreover, the patient reported remaining conscious during the entire
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episode and experienced no residual amnesia. The interictal EEG showed intense and very
frequent irritative activity with a burst of epileptiform discharge in the left frontal area and a
generalised spike-wave complex (Figure 3).
True seizures were recorded during the spike-wave discharges, which were accompanied by
an altered state of consciousness, mild to severe difficulty to speak and a clear delay in response
to different orders (Figure 4).
During the episodes, no clear evidence of any ictal pattern emerged. We conducted an
induction test that proved positive, reproducing the previously described patient episodes
(Figure 4).
In addition to this type of seizure (of which the patient did not complain), the patient com‐
plained of severe and multi-day seizures of language emission and difficulties in understand‐
ing. The brain activity recorded during these episodes did not show a clear ictal pattern.
Nevertheless, the recorded bioelectrical activity needed to be classified as a seizure or another
disorder. To assess these recordings, we analysed the band coherence [C(f)] using to equation
1 and compared the basal and ictal activity using the c(f) equation. We hypothesised that a true
seizure most likely increases the local coherence for any scallop region (Figure 5). However,
as shown in Figure 5, the local coherence was not significantly modified from basal activity
during any of the recorded paroxysmal episodes.
Figure 2. A typical recording during the provocative induction test. The image corresponds to 25 s after a 2-ml saline
injection. The patient (inset) experienced myoclonus of all four limbs. Two neurophysiologist (LV-Z and JP) were moni‐
toring the patient’s response. The EEG recording showed no pathological activity, except for movement artefacts.
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Figure 3. Wakeful interictal activity shows a burst of generalised spike-wave complexes.
 
Figure 4. A burst of blunted spike-waves at 3 Hz shows a true alteration of
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Figure 4. A burst of blunted spike-waves at 3 Hz shows a true alteration of consciousness. The patient was ordered to
close her eyes (filled arrow), but the response was delayed by 6,4 s towards the end of the seizure. The HR (inset) in‐
creased from 72.8 ± 1.8 bpm before the burst to 83.7 ± 0.7 bpm during the episode (p < 0.05, ANOVA test by ranks)
and returned to 78.8 ± 0.9 bpm after the episode (p < 0.05, ANOVA test).
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Figure 5. Quantitative EEG recordings assess the presence of epilepsy. A) Recording during a typical seizure. The emp‐
ty arrow indicates when the patient pressed the patient-event button, which identifies the presence of a seizure. Dot‐
ted boxes indicate the basal (left) and ictal (right) periods selected for analysis. B) The EEG electrode schemes
represent the 10-20 IS on the scalp. Local coherence was obtained using equation 2 for every electrode and every fre‐
quency band. Coherence is related to the diameter of each electrode, and no significant differences were observed
between basal (left) and ictal activity (right).
Furthermore, after placebo injection, an episode was recorded that was similar to the sponta‐
neously recorded episode, and this reinforced a PNES diagnosis.
3.4. Psychiatric comorbidities and patient management
The rate of psychiatric comorbidities in PNES patients was 50%. Affective disorders were the
most frequent psychiatric diagnosis (10/15), in particular, depression and anxiety disorders.
Dissociative disorders were observed in 4 patients. Post-traumatic stress disorder was
diagnosed in the remaining patient (Table 2). Interestingly, no differences were observed in
the psychiatric comorbidities between the PNES+ E and PNES patients.
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Our preliminary data have confirmed reports in the literature detailing the higher disability
observed in PNES patients compared with epilepsy patients. To provide proper patient
management, we applied a protocol of patient management to all patients in our unit to
provide the appropriate care to PNES and PNES+E patients (Table 4). We have observed that
PNES patients showed good family integration, and both patients and families have adapted
to the disorder, even in an overprotective way.
Neurologist refers patients to the Unit.
First Step. All patients are assessed by a:
Neurologist
or Neurosurgeon (if the patient has been referred for a neurosurgical evaluation)
Second Step. Ancillary tests and other specialists:
Scalp EEG
Single Photon Emission Computed Tomography (SPECT) with 99Tc-HmPAO
MRI (1.5 T) with an epilepsy protocol
Psychiatrist
Neuropsychologist
Clinical decisions are determined in a regular multidisciplinary clinical meeting.
When PNES are detected, a more complex psychiatric assessment protocol is initiated
In patients with PNES, it is important to differentiate between PNES alone and PNES+E patients.
When patients suffer from PNES alone, a joint visit from a neurologist and psychiatrist are used to inform the patient
and if possible, the closest family member about:
The psychogenic basis of the disorder, the diagnostic process and the likelihood of individualised psycho-
etiopathogenic mechanisms of the disorder.
The high disability associated with the disorder is also emphasised.
The need to treat the disorder with psychiatric and psychotherapy approaches.
The patient receives a complete clinical report to facilitate treatment continuation in his/her health care district.
The appropriate way to reduce neurological medications is supervised by a neurologist.
A close neurophysiological EEG survey is always recommended, which occurs during the progressive withdrawal from
antiepileptic drugs.
Usually patients need to visit a neurologist and psychiatrist before completing care at his/her mental health centre.
When patients suffer from PNES+E, a joint visit from a neurologist and a psychiatrist is used to inform to the patient
and if possible, the closest family member about:
The psychogenic basis of the disorder, the diagnostic process and the likelihood of individualised psycho-
etiopathogenic mechanisms of the disorder. The high disability associated with the disorder is also emphasised.
The need to treat the disorder with psychiatric and psychotherapy approaches.
The patient is given a complete clinical report to facilitate mental health treatment in his/her health-care district.
An individualised and thorough study of epilepsy is crucial to before deciding on surgery. In a small number of
patients, epilepsy is detected during the vEEG, because of antiepileptic drug withdrawal; however, when AEDs are
reintroduced, only the PNES are clinically significant.
Table 4. Protocol of Patient Management at the National Referral Centre for Refractory Epilepsy
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4. Discussion
4.1. Characteristics of patients with non-epileptic seizures of psychogenic origin
We have found that 4.8% of patients referred to our epilepsy centre for pre-surgical evaluation
received a diagnosis of PNES. This percentage is lower than other published studies. However,
PNES was the most frequent non-epileptic condition diagnosed in our epilepsy monitoring
unit. Interestingly, in 90% of PNES+E patients, we discovered alterations in brain imaging
studies, and also in more than half of the PNES-alone patients, we detected alterations in brain
imaging studies. These findings have been previously described, and other researchers have
found MRI changes in up to 60% of PNES+ E patients and up to 10% of PNES-alone patients
[29]. If epileptiform activity is also considered as marker of brain abnormality, then the
percentage of PNES patients in this study with evidence of physical or functional brain
abnormalities was 55%. This percentage, though lower than in previously reported studies,
reinforces the theory that physical brain disease may play a role in PNES development and in
other somatoform and dissociative disorders [30, 31, 32].
In this study, early diagnoses were complicated by concomitant epilepsy or epileptiform
activity in 21 PNES patients; however, the semiology of the events helped differentiate PNES
from epilepsy (closed eyes, non-rhythmic movements, awareness during the ictal phase and
the ability of bystanders to modulate symptom intensity are more often observed in PNES).
Nonetheless, no single observation provides a definitive PNES diagnosis, and no single
semiological feature is shared by all PNES patients [33]. Moreover, eyewitness accounts of
semiology may not be reliable in many cases. Usually, it is difficult for an experienced clinician
to determine if an event is a true seizure or PNES, and generally, it is nearly impossible to rule
out a diagnosis of epileptic seizures. The gold standard for ruling out epilepsy is vEEG
telemetry that analyses typical seizures [34]. Observations of typical seizures combined with
recorded brainwave activity lead to accurate diagnosis in up to 90% of cases [35]. In our study,
3,7% of patients did not receive a positive diagnosis because the bioelectric abnormalities or
clinical manifestations typical of PNES were not observed. Thus, we could only conclude that
the patient had no evidence of epilepsy, but it is possible that these patients might actually
belong to the PNES group.
The diagnosis of PNES is difficult to obtain. In fact, the absence of epileptiform activity in scalp
recordings during the event is necessary, and evidence of this can be extremely difficult to
obtain, because a true partial seizure may have no significant changes in scalp recordings. In
these cases, it is necessary to perform a more complex brain activity analysis to reach a definite
and clear diagnosis. As misdiagnosis can lead to devastating consequences, all efforts should
be made to determine the appropriate diagnosis, and in these cases, provocative techniques
aid in providing a definitive diagnosis. We used these techniques in 9 patients to confirm a
PNES diagnosis, and they were positive for PNES in 7 patients. The observed clinical mani‐
festations were never associated with bioelectrical changes in the EEG recordings. The
sensitivity to induction is unknown but estimated at 30% [25]. The key factors in PNES
diagnoses are confirming that the habitual episode was indeed induced and always obtaining
a simultaneous vEEG. If the recorded episode is not the habitual type typically recognised by
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the patient and family, then a firm conclusion is unattainable, and most likely, the patient has
different types of episodes. Another important issue is the awareness of the different types of
seizures that can accompany a normal ictal EEG and which types cannot.
Another confounding factor in diagnosing PNES is that both epileptic seizures and PNES may
occur concomitantly. Up to a 40% of our patients experienced PNES and epilepsy. Some authors
estimated the prevalence of this comorbidity as ranging from 10% to 50% [36]. In 5 patients with
PNES+E, we performed resective surgery. This determination was based on the results of vEEG,
psychological and psychiatric assessments that suggested the decrease or disappearance of
epileptic seizures could increase patient quality of life. The outcome of these patients is good;
4 patients showed Engel’s grade I and the remaining patient an Engel’s grade II.
4.2. Psychiatric diagnosis
When considering psychiatric disorders, some authors have found no differences in the
prevalence of current axis I disorders in patients with recent-onset PNES+E [37]. Nevertheless,
in most studies, a high prevalence of psychiatric comorbidities has been found, and up to 90%
of PNES patients met the criteria for another psychiatric disorder, axis I or axis II, according
to the DSM criteria. Although a significant degree of psychopathology has been documented,
there is an absence of a unique character substrate. Despite numerous studies that have linked
PNES to a high prevalence of comorbid psychiatric conditions, we found a low percentage
(40%) of the PNES patients exhibited these disorders. Furthermore, we did not observe
differences in the psychiatric comorbid disorders of the PNES+E and PNES patient groups.
However, we only detected dissociative disorder and post-traumatic stress disorder (PTSD)
in the PNES-alone patients, but affective disorders were more common in the PNES+E group.
Other studies have shown that approximately 60% of patients met the criteria for an affective
episode [4, 5]. However, depressive symptoms are similar in PNES and epilepsy patients; thus,
a negative affect could be the result of a chronic illness rather than uniquely related to PNES
[38].
Other studies consider PNES as a heterogeneous entity, and to better understand it, different
predisposing, precipitating and modulating factors must be considered. Patients with PNES
usually present with a larger background of traumatic experiences than the general population
[39], with values ranging from 84% [5, 40] to approximately 40%, in more recent studies [4, 38,
41]. These studies have shown a higher incidence of adverse childhood experiences and life
events [42]. Previous trauma correlated with a high rate of psychiatric comorbidity and with
strong dissociative mechanisms [43]. Additionally, a consistent history of psychiatric treat‐
ment, suicide attempts, borderline personality disorder or a history of abuse have been
documented [44].
Regarding dissociative disorders, different but high prevalence rates of comorbid dissociative
disorders have been reported, which range from 37% to 80% of cases [4, 5]. Not only clinically
diagnosed dissociative disorders but dissociative experiences appear to be more frequent in
PNES patients, as measured with the Dissociative Experience scale (DES). Patients with
epilepsy and PNES scored significantly higher on the DES than patients with epilepsy without
PNES and non-epileptic individuals [45]. Nevertheless, these diagnoses have not been
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consistently correlated with significant differences in dissociative and conversion trait scores
as determined with the Minnesota Multiphasic Personality Inventory (MMPI) [4].
Somatic syndromes, such as fibromyalgia, chronic fatigue syndrome, chronic pain syndrome
or tension headaches, and irritable bowel syndrome, have occurred at a higher frequency in
PNES patients than in other patients with epilepsy [46, 47]. Other medical conditions, such as
cancer, orthopaedic problems, and multiple surgeries, were also more frequent in the PNES
group than in the epilepsy group.
In PNES patients, this high prevalence of somatic syndromes could be related to a higher risk
of manifesting psychic conflicts through somatic symptoms. In fact, PNES has been considered
as a somatic symptom response to a wide range of negative events, including stress in
adulthood [38].
4.3. Psychological profile
As we analysed the psychological evaluations from our study, we realised that the amount of
information from the psychological profiles and psychopathological mechanisms warrants an
extended discussion of both topics. Therefore, we will discuss the psychopathological mech‐
anisms separately in the next section.
Most PNES patients met the criteria for a diagnosis of an axis II personality disorder (around
60%) [4, 5], but patients with ES also had an increased prevalence of personality disorders. The
prevalence of personality disorders in ES patients 34.3%, which was significantly higher than
healthy controls.
Nevertheless, some significant differences exist in the types of personality disorders diagnosed
in the PNES and ES patients. In the ES group, the most common personality disorders were
cluster C personality disorders (i.e., avoidant, dependent, and obsessive-compulsive disor‐
ders) [48, 49, 50], and in PNES patients, cluster B personality disorders were more common
(i.e., antisocial, borderline, histrionic and narcissistic disorders) [49, 50, 51, 52, 53,]. The
presence of personality disorders is associated with a poor prognosis, diminished quality of
life, and increased resource use in both PNES and ES patients [3, 4, 48, 51].
When personality traits have been assessed and specialised instruments used, a general,
complex, and diverse psychological profile has been obtained, as evaluated with both neurotic
and psychotic scales [4, 54]. Thus, PNES personality profiles do not reveal a specific, unique
syndrome [55].
The MMPI has been the most widely used inventory to classify personality traits. The higher
personality assessment scores have been in somatisation and externalisation; these patients
have a strong preference for a medical explanation for their symptoms and tend to project the
burden of their symptoms to their environment instead of a possible psychological explanation
for their disorder [29, 55]. It is interesting to note that families of psychogenic seizure patients
have also been found to be more prone to somatic problems and emotional distress than
matched controls with epilepsy [56], hypochondriasis and conversion traits [4, 57].
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Dissociation scores have been widely studied and, on average, are higher in PNES patients but
not significantly higher [7, 45, 58, 59]. Dissociative trait scores were higher in patients with a
reported trauma [7].
Additionally, an anxious, practical and perfectionist attitude with difficulties tolerating
ambiguity and a strong need to control have also been reported [55]. Another study described
increased shyness [7], which has been related to antisocial behaviour and a high tendency to
internally control emotions [55].
PNES has been associated with an alexithymic pattern and a lack of psychological awareness
of the causes and consequences of their psychological dysfunction [55]. Although alexithymia
appears to be elevated in PNES, it has also been elevated in epilepsy patients [38]. PNES has
been significantly correlated with symptoms of anxiety, autonomic hyperarousal, dissociation
and defensive avoidance, which are all characteristic of traumatic experiences. Thus, alexi‐
thymia has been hypothesised as a deficit that results from physiological and cognitive
dysregulation following post-traumatic stress disorder [60].
Another personality trait of PNES patients is difficulty with coping strategies. Elevated levels
of perceived distress and a lack of coping strategies, such as a passive and/or avoidant attitude
to resolve psychological problems in other ways [3, 61, 62], make it difficult to employ
strategies that would normally be used to reduce the impact of a stressor [63]. Some effective
minimal coping strategies, such as emotion-focused coping strategies, are more frequently
used than effective coping strategies, such as task-focused strategies [60]. These features lead
to difficulties in emotional experiences to daily life situations, and diminished positive
emotional behaviour has also been reported [64].
Two emotion dysregulation profiles have been described [65], a high level of emotion dysre‐
gulation associated with severe psychiatric symptomatology and impaired quality of life and
low emotion dysregulation that is characterised by emotional unawareness or avoidance.
Some common personality traits as well as some clinical similarities have been documented
between PNES and borderline personality disorder patients. Higher prevalence rates of sexual
trauma, posttraumatic stress disorder, dissociative disorders, somatoform disorders, depres‐
sive disorders, anger problems, suicide attempts, emotional instability and hostile coping
styles have been reported in both conditions [49, 50, 52, 66].
Some similarities in personality traits have also been found between PNES and patients with
functional somatic symptoms disorders [55].
Although the interpersonal relationships of PNES patients in clinical practice appear to be deeply
affected, their social functioning scores remain within normal limits [4]. These patients make
instrumental use of the PNES, which may contribute to the perception of being well-adapted
in their relationships. Patients with higher emotional dysfunction and higher abnormal
personality traits have a lower quality of life [47].
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4.4. Etiopathogenic models of PNES
The final symptomatic expression of PNES remains unclear. Some etiopathogenic theories that
comprehensively address many factors have been previously reported and have been hypoth‐
esised to explain psychogenic seizures.
Bodde y cols [55] considered factors that predispose patients to psychosomatic symptoms and
increase PNES vulnerability.
Sexual abuse, other traumatic experiences, organic vulnerability (such as head trauma) and
personality factors (emotional profile or neuropsychological functioning) increase PNES
vulnerability. Stressful childhood events, including parental divorce and physical abuse [67],
other childhood trauma and family dysfunction [68] also increase PNES vulnerability.
The observed personality traits have a tendency towards somatisation or dissociative experi‐
ences or reaction with somatic symptoms of psychological distress [7]. Alexithymia, cognitive
inflexibility and hypervigilance have also been considered as PNES vulnerability factors [69].
Factors that shape patient perceptions could explain the presence of seizures and not other
functional disorders, such as past epilepsy or having a close friend or relative with epileptic
seizures. When examined, personally witnessing a seizure prior to their own attack occurs
significantly more often in patients with PNES than in patients with epileptic seizures [67, 70].
Triggering factors, such as some psychological mechanisms or psychosocial events, might
provoke seizure onset at specific moments. PNES patients report more events than epilepsy
patients or patients with motor conversion disorders [67].
Thus, prolongation factors could explain the persistence of PNES over time.
The modulating factors, e.g., personality [3], patient coping style and secondary gain aspects,
could also contribute. There are some criticisms of secondary gain, as this benefit can be
observed in almost any illness [67].
4.5. PNES subtypes
In general psychopathology, somatisation, alexithymia and difficulties with most aspects of
emotional regulation could be the most important factors in the etiopathogenesis of PNES [71].
Considering all the etiopathogenic factors, some studies have proposed different etiopatho‐
genic subgroups.
Reuber and House [2] classified PNES into 3 groups based on the most prominent psychiatric
comorbidity profiles: an anxiety-depressive group with depressive or anxiety symptoms,
including panic and post-traumatic stress disorder (PTSD), a somatisation and abnormal
illness group and a borderline personality group.
Bodde et al. [55] proposed 4 etiopathogenic groups: a psychotrauma subgroup, a high
vulnerability somatisation subgroup (approximately 1/5 of patients), a sensitive personality
subgroup (less than 1/5 of the patients) and a high vulnerability somatisation, low cognitive
level subgroup with daily life stress.
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Other authors proposed a more simplified, two-subgroup etiopathogenic classification
scheme: a posttraumatic PNES group, characterised by psychogenic attacks that develop in
response to acute or chronic traumatic experience exposure, and developmental PNES group,
characterised by difficulties in coping with tasks and milestones on the individual's psycho‐
social development continuum [71].
The importance of diagnosis presentation
The first step towards symptom improvement is presenting the diagnosis to the patient and
when appropriate, to his or her family. Providing patients with a PNES diagnosis, appears to
reduce PNES frequency in the months following diagnosis in at least one third of patients [69,
72, 73, 74, 75, 76].
A marked reduction in health care demand after PNES diagnosis has also been established by
prospective follow-up studies [10, 69, 77]. However, long-term studies examining the decrease
in PNES frequency shortly after diagnosis has not been maintained longitudinally when a
diagnosis is the main and sole "intervention" [3, 58].
Effectively communicating the PNES diagnosis in an understandable and acceptable way to
the patient and family is critical and is considered the first therapeutic step.
The process of explaining to the patients that their disease may be psychiatric instead of
neurological must be cautiously and progressively handled [16]. Patients and family must be
engaged in a treatment plan very different from the previous plan.
A significant patient and family resistance to a new and non-neurologic diagnosis requires the
implementation of coordinated strategies by a neurologist and a psychiatrist to manage the
best outcome for these patients. When a diagnosis is given to patients and families, some of
patients have a sense of relief to know that the events are not epileptic and that they will be
helped in identifying sources of stress and other emotional problems responsible for triggering
their events [75]. However, most patients react negatively to the diagnosis of PNES. Frequently,
they feel that doctors are communicating that the symptoms are not real but invented.
Many factors may contribute to this negative, even hostile, attitude towards a psychogenic
basis of their crisis [46, 52]. Some personality trait factors, such as somatisation and external‐
isation traits, make diagnosis acceptance difficult. Patients and families show a tendency to
seek medical responsibility for these symptoms and might be very reluctant to be referred for
psychological or psychiatric treatment.
An indirect benefit obtained through this behavioural pattern may also help explain their
resistance to change [4].
Another factor related to the initially hostile attitude of the patients is the risk of stigma, which
is inherent to psychiatric disorders. Patients fear being viewed as malingerers or attention
seekers [74], and also the not infrequent stigmatisation of the doctor, who only considers
neurologic diseases real diseases, may transmit this bias that a psychogenic crisis is not a real
disease to patients. These stigmatising views can lead patients to believe that they do not need
attentive specialised and technical care but a psychiatric clinic for insane individuals.
Epilepsy Topics210
All these difficulties in the diagnosis and treatment of PNES patients must be considered when
deliberating over the most effective strategy to provide information about a PNES diagnosis
to patients previously considered neurologic patients.
A good therapeutic relationship between the neurologist and patient is crucial. One or several
clinical interviews involving a neurologist, psychiatrist and patient that provide a multidisci‐
plinary presentation of the diagnosis and treatment plan are highly recommended.
When presenting a PNES diagnosis, it is recommended to explain to patient and family the
lack of ictal discharges during vEEG, the psychogenic nature of the attacks as a result of
difficulties managing stressful or life situations, the acknowledgement that the attacks are real
and out of the patient's control and the need for psychotherapeutic and/or psychiatric treat‐
ment to managing stressful situations and psychiatric comorbidities. Unless patients and
families understand and accept the diagnosis, they typically will not comply with recommen‐
dations and will not follow-up with a psychiatrist.
A neurologist will continue to provide care, monitoring the patient outcome, and progressively
decreasing antiepileptic drug doses when appropriate.
If patients present with both PNES and epilepsy and antiepileptic drugs must be maintained,
patients will need to be informed and must understand both the neurologic and psychiatric
treatments. However, some controversy exists about the discontinuation of antiepileptic drugs
in PNES patients without epilepsy. Antiepileptic drugs could provide therapeutic benefits on
mood and impulsivity and for headache or pain prophylaxis. On the contrary, toxicity,
teratogenicity and medication expense need to be considered [78].
4.6. Treatment
The treatment plan must be individually adjusted to each patient, depending on the psycho‐
genic factors considered to underlie the psychopathology [7, 79, 80].
For example, if difficulties in emotional reactions occur, some strategies, such as monitoring
symptom triggers, re-interpreting physical sensations and increasing relaxation, could be
effective in PNES patients [64].
4.7. Psychotherapy
Most psychotherapy techniques, such as psychodynamic interpersonal psychotherapy, group
psychodynamic psychotherapy and group psychoeducation, have been evaluated in uncon‐
trolled trials. These interventions all seem promising but require further investigation in larger
scale samples and/or more rigorous methodology.
4.8. Cognitive-Behavioural Therapy (CBT)
CBT is based on the conceptualisation of PNES as dissociative responses to arousal when a
patient is confronted with stimuli or circumstances that the patient tends to avoid, consciously
or not.
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Patients with PNES tend to display significantly distorted somatic beliefs and develop
dysfunctional, repetitive illness behaviour patterns with associated depressive affect as well
as a sudden and time-limited disturbance in controlling cognitive, emotional, and/or behav‐
ioural functions [70, 79]. CBT is intended to modify distorted beliefs and change the perception
of the limitations associated with PNES.
This therapy may be useful several symptom patterns: (a) acute anxiety/panic, (b) impaired
affect regulation and interpersonal skills, (c) somatisation/conversion, (d) depression, (e)
PTSD, and (f) reinforced behavioural patterns [80]. These classifications were based on the
most effective psychotherapeutic interventions for each patient group.
CBT is the only psychotherapeutic PNES intervention that has been studied in a randomised,
controlled pilot trial and is therefore the psychotherapeutic treatment with the highest level
of efficacious evidence (Class III) in this population. Goldstein et al. [81] reported that in an
open-label trial for patients with dissociative seizure, a 12-session CBT intervention was
significantly more effective than standard medical care (SMC) for reducing seizure frequency
in PNES patients. Psychotherapy focused on the following factors: engagement in treatment,
reinforcement of independence, distraction, relaxation, refocusing techniques at the earliest
signs of an event, graded exposure to avoided situations, cognitive restructuring, and relapse
prevention. A tendency for this benefit to persist was maintained at the 6-month follow-up.
There was also an overall improvement in self-rated social functioning of the CBT group
compared with SMC.
Moreover, an uncontrolled CBT study where therapy was focused on addressing cognitive
distortions and promoting behavioural changes has been published [82]. Some specific
objectives of the psychotherapeutic sessions included the study of the individual's context,
identification of moods, situations, and thoughts, training in healthy communication and
support seeking, understanding central nervous system medications and seizures, conducting
a functional behavioural analysis, developing relaxation techniques, examining external
stressors and internal triggers, and preparing for life after completing the time-limited
intervention. Patients reduced the number of PNES and improved quality of life, family
functioning, and psychosocial functioning.
In summary, the data on CBT efficacy for PNES treatment are sparse but promising.
4.9. Group therapy
To date, several studies have reported the use of group therapy for PNES patients.
Zaroff et al. [83] evaluated the effectiveness of group psychotherapy based on psychodynamic
theories and a psychoeducational session structure. All patients included in this open-label
trial participated in a one-hour weekly group psychotherapy session for a total of 10 weeks.
In each session, the following relevant PNES topics were discussed: PNES, anger, trauma and
abuse, depression and anxiety, somatisation tendencies, quality of life, paths toward health,
stress coping techniques and topic review. At the conclusion of the 10-week program, group
psychotherapy continued in a less structured and more supportive format without specific
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session topics. The substantial percentage of individuals whose seizures remitted following
diagnosis supports the hypothesis that education about the disorder is an effective treatment.
The results of a six-month psychotherapy group, with an open, uncontrolled design [84], have
been published. Over a total of 24 sessions, the discussion of feelings related to past or present
events relevant to PNES was encouraged. A decrease in seizure frequency was reported in six
of the nine PNES subjects (67%).
In another pilot study with a psychodynamic focus and psychoeducational structure, self-
relaxation with hypnosis was also used [85]. Dissociation was considered a defence mechanism
that splits traumatic memories from consciousness because they are inconsistent with the
patient's self-concept. The goal of therapy was to facilitate the patient's awareness of these
patterns and to thus allow change. The development of assertive coping strategies instead of
passive avoidant behaviour was emphasised. The study reported an overall decrease in seizure
frequency and a significant improvement in different psychometric assessments.
Recently, another uncontrolled study with group psychotherapy has been published [86].
Psychoeducation and behavioural and psychoanalytic techniques were utilised. Nine patients
completed 12 weeks of psychotherapy. In this therapy, families gathering four times for 1 h
during the study provided a different treatment element. Families were not included in the
therapeutic process and met just before the group sessions. Families were encouraged to ask
questions and talk about seizures, and behavioural management strategies were advised. A
sustainable decrease in seizure frequency, which lasted from the beginning of the therapy until
the 12th month of follow-up, was observed. All patients showed a >50% reduction in seizure
frequency.
4.10. Paradoxical intention therapy
This technique has been used in PNES and conversion disorder patients. In a randomised trial
of PNES patients, Ataoglu et al. [87] tested inpatient paradoxical intention (PI) therapy versus
oral outpatient benzodiazepine. PI therapy consisted of encouraging patients to intentionally
engage in their unwanted conversion symptoms. This study did not focus on crisis frequency
but on conversion symptoms. Both groups recorded significantly decreased anxiety scores by
the end of treatment.
4.11. Hypnosis
Given the theoretical importance of dissociation in PNES aetiology, hypnosis would appear
to offer a useful intervention for this patient population [72]. The effectiveness of hypnosis was
evaluated in a prospective study [88] where 49 patients were randomly assigned to either a
hypnosis-based 10-week session treatment for conversion disorder, motor type, or a wait list
control group. Only two patients in this conversion disorder study had PNES. A significant
improvement in the Motor Conversion Symptoms scale (VRMC) for the treatment group was
observed.
Other studies evaluated dissociation and hypnotisability in PNES patients and compared them
with a nonclinical control group or epilepsy patients. In one study, PNES patients had higher
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levels of dissociation and hypnotisability as measured by the Dissociative Experience Scale
(DES) [61]. Hypnotisability was also significantly higher for the PNES group compared with
the control group, as other authors have previously reported [89].
4.12. Pharmacological treatment
To date, the lack of a consistent neurobiological model explaining PNES physiopathology
makes it considerably difficult to identify a specific and effective pharmacological treatment.
Owing to a lack of large, controlled trials evaluating the efficacy of different treatment
modalities, guidelines on how to treat this complex health problem do not exist [16, 79].
Nonetheless, under the premise that some of the factors that seem to be involved in PNES
etiopathogenesis, such as depressive mood and anxiety, are associated with serotonergic
neurotransmission alterations, selective serotonin reuptake inhibitors (SSRIs) have been
investigated as potentially useful drugs. In addition to their established efficacy for treating
depression and anxiety [90, 91], SSRIs have shown promise in trials for conversion or soma‐
toform disorders [92] and some personality disorders [93]. These disorders are frequently
occurring comorbidities in PNES patients, which make SSRIs particularly attractive as a
potential treatment.
LaFrance et al. conducted a randomised, double-blind, placebo-controlled clinical trial (which
meets the criteria for Class II evidence) evaluating the efficacy of flexible-dose sertraline over
12 weeks at reducing PNES frequency and improving other symptom severity and psychoso‐
cial measures [94]. Patients were allowed to participate even with previous antidepressant use,
except for monoamine oxidase inhibitors or sertraline at a 100 mg/day or higher dose, to
maintain a constant dose of the concurrent antidepressants for the study duration. The
sertraline group experienced a 45% decline in biweekly seizure rates over the 12-week course
of the intervention from 22.24 to 12.18 (ratio, 0.55; 95% CI, 0.32-0.93; p = 0.03), while the control
group showed an 8% increase from 13.38 to 14.38 (ratio, 1.08; 95% CI, 0.65-1.77; p = 0.78).
However, the limited sample size (33 patients were included in the final analysis) implied this
study was underpowered and unable to detect statistically significant differences between
groups (RR, 0.51; 95% CI, 0.25-1.05; p = 0.29). There were no differences in secondary outcome
measure changes between the groups (a series of scales assessing different psychiatric
symptoms, functionality and quality of life-related measures). The evaluation of SSRIs in
larger, randomised, controlled trials is therefore necessary to establish solid treatment
guidelines.
Venlafaxine, a noradrenalin-serotonin reuptake inhibitor (NSRI), has also been evaluated as a
potential psychopharmacological PNES treatment. An open-label, prospective, uncontrolled
study evaluated the efficacy of flexible-dose venlafaxine on seizure frequency reduction and
anxiety and depression disorder severity improvement [95]. All enrolled subjects had vEEG-
confirmed PNES but also met the DSM-IV criteria for a unipolar depressive disorder and/or
anxiety disorder. The 19 subjects who completed the 5-month follow-up experienced a
statistically significant reduction in all symptom scales and monthly event frequency at the
five-month assessment compared with the initial assessment; however, no differences were
detected in the patient subgroup with more than ten events in the 15-day baseline pre-inclusion
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assessment period. The particular comorbidities of the patients included in this study prevent
the extrapolation of the results to the broader PNES population, but the combined prevalence
of depressive and anxiety disorders among PNES patients that may reach up to two thirds of
PNES patients should not be ignored [4]. An additional caution when interpreting these results
is the lack of a placebo-arm, especially if we consider the documented initial decrease in seizure
frequency consistently observed during the first months after PNES diagnosis [16, 73, 75, 76].
This factor could account for some of the event frequency reductions described in this study.
Clinicians have often tried other pharmacological PNES treatments based on current knowl‐
edge of PNES-related disorders. As we have previously described, patients suffering from
PNES share many underlying psychopathological characteristics with other conversion and
somatoform disorders. These comorbidities may lead to the hypothesis that treatments
demonstrating efficacy for these other disorders might also provide some benefit in PNES.
Evidence-based treatments for other conversion disorders have been documented in uncon‐
trolled trials. A retrospective study on patients with psychogenic paralysis showed that
repetitive Transcranial Magnetic Stimulation (rTMS) over the motor cortex contralateral to the
corresponding paralysis achieved improvement in 62 of 70 patients (89%), with total recovery
observed in 53 patients (76%) [96].
In an open-label, prospective study conducted on 23 patients diagnosed with chronic psycho‐
genic movement disorder (PMD), antidepressant medications (paroxetine, citalopram and
venlafaxine) showed a reduction and even remission of psychogenic movements in the
subgroup of patients in which the movements were not accompanied by other somatoform
disorders, such as hypochondriasis or somatisation disorders [92]. Various classes of antide‐
pressants have also demonstrated a reduction in medically unexplained symptoms, including
headache, fibromyalgia, functional gastrointestinal syndromes, idiopathic pain, tinnitus, and
chronic fatigue [97].
In summary, no strong evidence exists to date that establishes the efficacy of any particular
medication for the treatment of PNES. Despite this fact, preliminary studies suggest that
sertraline and venlafaxine could be beneficial therapeutics. The data investigating treatments
for PNES-related disorders also support this hypothesis
5. Conclusions
PNES is one of the most frustrating clinical pathologies. Diagnosis is sometimes difficult and
can take several years to reach a definitive PNES diagnosis. Moreover, treatment can be even
more difficult. However, PNES is a severely debilitating illness for the patient, family and
society; thus, we must continue to identify and improve patient quality-of-life. Nevertheless,
a significant percentage of patients referred to epilepsy surgery units present with PNES,
where the necessary assessments, such as vEEG, can provide a correct diagnosis; therefore, the
actual magnitude of PNES diagnoses may be larger than currently detectable.
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Hence, when assessing patients with epilepsy, the PNES pathology should be kept in mind
and patients should be sent to a specialised unit, even under the minimal suspicion of PNES,
to provide a correct diagnosis in a timely manner. These steps should minimise medication
side-effects and consumption of health care resources and offer the patient the most efficacious
treatment.
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